Released Aug 7, 2018, after the close
10-Q filed Aug 8, 2018, 39 days after period end · 0001162194-18-000089
Q2 2018 · 10-Q
Revenue$26.43M$26.43M +10.5% vs Q2 2017+4.7% vs Q1 2018
Net Income-$16.24M-$16.24M N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.42-$0.42 N/M vs Q2 2017N/M vs Q1 2018
Gross Profit$13,588,000—
Operating Income-$12,785,000N/M
Operating Cash Flowderived-$4,323,000N/M
Free Cash Flowderived-$4,400,000N/M
Margins · derived
Gross margin51.4%
Operating margin-48.4%+20.6 pt vs Q2 2017
Net margin-61.5%+9.4 pt vs Q2 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $26.43M | $23.91M | $28.17M | $28.62M |
| Net Income | -$16.24M | -$16.93M | -$18.62M | -$15.24M |
| EPS Diluted | -$0.42 | -$0.58 | -$0.64 | -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR